Number of the records: 1
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
- 1.0565105 - BTÚ 2023 RIV US eng J - Journal Article
Ryšánek, D. - Vasicová, P. - Kolla, J. N. - Sedlák, D. - Anděra, Ladislav - Bartek, J. - Hodny, Z.
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells.
Aging. Roč. 14, č. 16 (2022), s. 6381-6414. ISSN 1945-4589
Institutional support: RVO:86652036
Keywords : homoharringtonine * cellular senescence * bcl-2 * mcl-1 * senolytics
OECD category: Cell biology
Impact factor: 5.2, year: 2022
Method of publishing: Open access
https://www.aging-us.com/article/204207/text
Accumulation of senescent cells in tissues with advancing age participates in the pathogenesis of several human age-associated diseases. Specific senescent secretome, the resistance of senescent cells to apoptotic stimuli, and lack of immune system response contribute to the accumulation of senescent cells and their adverse effects in tissues. Inhibition of antiapoptotic machinery, augmented in senescent cells, by BCL-2 protein family inhibitors represents a promising approach to eliminate senescent cells from tissues. This study aimed to explore synergistic and selective senolytic effects of anti-apoptotic BCL-2 family targeting compounds, particularly BH3 mimetics.
Permanent Link: https://hdl.handle.net/11104/0337614
Number of the records: 1